Balázs, G.; Balajthy, A.; Seri, I.; Hegyi, T.; Ertl, T.; Szabó, T.; Röszer, T.; Papp, Á.; Balla, J.; Gáll, T.;
et al. Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies. Antioxidants 2023, 12, 1149.
https://doi.org/10.3390/antiox12061149
AMA Style
Balázs G, Balajthy A, Seri I, Hegyi T, Ertl T, Szabó T, Röszer T, Papp Á, Balla J, Gáll T,
et al. Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies. Antioxidants. 2023; 12(6):1149.
https://doi.org/10.3390/antiox12061149
Chicago/Turabian Style
Balázs, Gergely, András Balajthy, István Seri, Thomas Hegyi, Tibor Ertl, Tamás Szabó, Tamás Röszer, Ágnes Papp, József Balla, Tamás Gáll,
and et al. 2023. "Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies" Antioxidants 12, no. 6: 1149.
https://doi.org/10.3390/antiox12061149
APA Style
Balázs, G., Balajthy, A., Seri, I., Hegyi, T., Ertl, T., Szabó, T., Röszer, T., Papp, Á., Balla, J., Gáll, T., & Balla, G.
(2023). Prevention of Chronic Morbidities in Extremely Premature Newborns with LISA-nCPAP Respiratory Therapy and Adjuvant Perinatal Strategies. Antioxidants, 12(6), 1149.
https://doi.org/10.3390/antiox12061149
